Gemcitabine (G) and cisplatin (C) as first-line treatment of metastatic breast cancer (MBC): Results of phase II trial.
Meinolf Karthaus
Honoraria - Lilly
Other Remuneration - Lilly
Irina Poddubnaya
No relevant relationships to disclose
L. Churilova
No relevant relationships to disclose
R. Khazanov
No relevant relationships to disclose
T. Veremeychuk
No relevant relationships to disclose
E Rumyantzeva
No relevant relationships to disclose
M. Garin
No relevant relationships to disclose
O. Brichkova
No relevant relationships to disclose
Bernhard Heinrich
Research Funding - Lilly
Volker Heinemann
Consultant or Advisory Role - Lilly
Honoraria - Lilly
Research Funding - Lilly
Other Remuneration - Lilly